Back to stock search

Summit Therapeutics PLC

SMMT•NASDAQ•HEALTHCARE
$15.42+1.04 (+7.23%)
Market closed•Prev close $14.38
Save to watchlist

AlphaYou read

Buy

Live call

C-suite insider bought $50.0M of SMMT this 14d.

Saved Jun 12, 2026· tracking vs the S&P 500

1 sourceOld
AlphaYou target

+5% to +15%

Over 30 days · baseline band

Analyst target

+83.6% ($28.31)

Over 12 months

Looks good

Co-Chief Executive Officer Zanganeh Mahkam bought $50.0M

Watch risk

Negative ROE (-270.9%) - capital destruction

Tracking

Day 20 of 30D, +9.3% vs the S&P so far.

What's driving it

  • Smart money
  • Fundamentals
  • Technicals
  • Macro
Set alertOpen latest callView proofCheck the math

Price

Stock chart

3calls marked
Prior call3

Snapshot

Quick facts

Updated Jul 2
Market cap
$11.31B
52-week range
$12.55 - $30.98
Volume
7.09M
Sector
HEALTHCARE

Analysts

What do analysts expect?

Live

Current

$15.42

Target

$28.31

+12.89 (+83.6%) possible upside12 months

Saved calls

Recent AlphaYou calls for this stock

LiveAll calls
  • LONGJun 12
    Insider Buy

    C-suite insider bought $50.0M of SMMT this 14d.

    Public call·Results pending
  • LONGJun 12
    Insider Buy

    C-suite insider bought $50.0M of SMMT this 14d.

    Public call·Results pending
  • LONGJun 5
    Insider Cluster

    C-suite + 2 other insiders bought $3.6M of SMMT this 14d.

    Public call·Results pending

Smart money

What big buyers and insiders are doing

Live17 items

  • insider buy

    Co-Chief Executive Officer Zanganeh Mahkam bought $50.0M

    +149961600.0
  • Citadel

    Citadel

    Citadel Advisors LLC holds $43.3M (13F 2025-12-31)

    +4.0
  • Two Sigma

Two Sigma

Two Sigma Investments LP holds $18.6M (13F 2026-03-31)

+4.0

  • filing 13f fund flow

    FMR LLC (Fidelity) holds $233.7M (13F 2025-12-31)

    +3.0

  • short interest change

    short-volume tape softening: latest 41.9% fell 19.0pp vs 20d avg 60.9%

    +2.0

  • insider buy

    Co-Chief Executive Officer DUGGAN ROBERT W bought $50.0M

    +149961600.0